Advertisement
Advertisement

SABS

SABS logo

SAB Biotherapeutics, Inc. Common Stock

1.15
USD
+0.03
+3.15%
Apr 08, 15:59 UTC -4
Closed
exchange

After-Market

1.15

0.00
+0.44%

SAB Biotherapeutics, Inc. Common Stock Profile

About

SAB Biotherapeutics Inc. is a clinical-stage biopharmaceutical company advancing a new class of immunotherapies leveraging fully human polyclonal antibodies. It produces natural, specifically targeted, high-potency, human polyclonal immunotherapies. SAB Biotherapeutics Inc., formerly known as Big Cypress Acquisition Corp., is based in SIOUX FALLS, S.D.

Info & Links

CEO

Samuel J. Reich

Headquarters

777 W 41st St, Suite 401
Miami Beach, FL 33140, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.sabbiotherapeutics.com

Auditor

EisnerAmper LLP

Share holders

254

Employees

63

SAB Biotherapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

10.68M

Enterprise Value

5.48M

Enterprise Value/EBITDA(ttm)

-0.14

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

6.47

Price to Book(mrq)

0.49

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

75.00%

Operating Margin(ttm)

-1450.11%

Profit Margin(ttm)

-2703.38%

Return on Equity(ttm)

-94.37%

Return on Invested Capital(ttm)

-87.15%

Return on Assets(ttm)

-67.26%

Income Statement

Revenue(ttm)

1.32M

Revenue Per Share(ttm)

0.14

Gross Profit(ttm)

1.32M

EBITDA(ttm)3

-38.36M

Net Income Available to Common(ttm)

-34.11M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

0.40

52-Week Change

-73.62%

S&P 500 52-Week Change

-4.22%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

9.29M

Dividend Yield

0.00%

Float4

6.79M

% Held by Insiders

26.46%

% Held by Institutions

7.82%

Balance Sheet

Total Cash(mrq)

20.76M

Total Cash Per Share(mrq)

2.24

Total Debt(mrq)

3.69M

Total Debt/Equity(mrq)

9.36%

Current Ratio(mrq)

3.69%

Quick Ratio(mrq)

3.69%

Book Value Per Share(mrq)

4.00

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.67

Free Cash Flow(ytd)

-25.04M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement